Dapagliflozin Tablet, Film Coated
Product Images NDC 50090-7972

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dapagliflozin (NDC 50090-7972). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Scatter Plot And Fitted Line Of Change From Baseline In 24-hour Urinary Glucose Amount Versus Dapagliflozin Dose In Healthy Subjects And Subjects With Type 2 Diabetes Mellitus (t2dm) (semi-log Plot) (Dapagliflozin Fig1)

A scatter plot showing observed values and fitted lines of CFB in 24-hour urinary glucose (g) versus Dapagliflozin dose (mg) on a logarithmic scale. The plot compares healthy subjects and subjects with T2DM, with different markers and trend lines for each group.*

FDA Label Image

Figure 2: Adjusted Mean Change From Baseline Over Time In Hba1c (%) In A 24-week Active-controlled Study Of Dapagliflozin Initial Combination Therapy With Metformin Xr (Dapagliflozin Fig2)

A line graph showing HbA1c (%) adjusted mean change from baseline over 24 study weeks for dapagliflozin 10 mg, metformin, and dapagliflozin 10 mg plus metformin. The left side shows longitudinal changes in three groups, and the right side presents adjusted mean change with 95% confidence intervals at Week 24 using last observation carried forward analysis.*

FDA Label Image

Figure 3 (Dapagliflozin Fig3)

A line graph showing adjusted mean change from baseline in HbA1c (%) over 24 study weeks comparing Placebo + Metformin and Dapagliflozin 10 mg + Metformin. The X-axis represents study weeks from 0 to 24, and the Y-axis shows percentage change in HbA1c. Two lines, one with squares for Placebo + Metformin and one with triangles for Dapagliflozin 10 mg + Metformin, illustrate decreasing HbA1c values over time, with Dapagliflozin showing a greater reduction. A side plot displays mean changes at Week 24 with 95% confidence intervals.*

FDA Label Image

Figure (Dapagliflozin Fig4)

A line chart comparing the percentage of patients with an event over months from randomization for Dapagliflozin versus placebo. The x-axis shows months from randomization (0 to 60), and the y-axis shows the percentage of patients with an event (0% to 7%). Two lines represent Dapagliflozin and placebo, with the placebo line showing a higher percentage of events. A table below the graph lists the number of patients at risk over time for both groups.*

FDA Label Image

Figure (Dapagliflozin Fig5)

A Kaplan-Meier curve showing the percentage of patients with event over time, comparing Dapagliflozin and placebo groups over 60 months. The y-axis represents the percent of patients with event, while the x-axis shows months from randomization. The graph also includes patient numbers at risk for both groups at various time points.*

FDA Label Image

Chemical Structure (Dapagliflozin Str)

Chemical structure of dapagliflozin showing its molecular arrangement with hydroxyl groups, a chlorine-substituted aromatic ring, and an ether-linked methoxy group.*

FDA Label Image

Label Image (Lbl500907972)

Dapagliflozin 10 mg film-coated tablet label from A-S Medication Solutions. The label shows product NDC 50090-7972-0 and indicates each tablet contains 10 mg of dapagliflozin. Storage recommended at 68 to 77 degrees Fahrenheit. Pack contains 30 tablets. Includes barcode and dosage instruction note to see the package insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.